Indication · Ophthalmology
Glaucoma
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
262
Cleared or approved since 2000
PMA and De Novo
15
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
62
573 device trials in all
Devices
247 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- SPECTRALIS HRA+OCT and variants
Heidelberg Engineering GmbH · 510(k) · Tomography, Optical Coherence · newest 2026 · 9 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)Completed
Sight Sciences, Inc.Not on our public-company list
NCT06948773 · 25 participants · Start May 21, 2025 · Primary completion Sep 7, 2026
Device: Helix Surgical System · For: Primary Open Angle Glaucoma; Cataract
Sites: Panama City, Panama
572 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Laser, Ophthalmic (HQF)87
- Tomography, Optical Coherence (OBO)40
- Tonometer, Manual (HKY)36
- Ophthalmoscope, Ac-Powered (HLI)28
- Tonometer, Ac-Powered (HKX)27
- Pump, Infusion, Ophthalmic (MRH)12
- Intraocular Pressure Lowering Implant (OGO)11
- Implant, Eye Valve (KYF)8
- Perimeter, Automatic, Ac-Powered (HPT)6
- Prism, Gonioscopic (HKS)1
- Lens, Surgical, Laser, Accesssory, Ophthalmic Laser (LQJ)1
- Apparatus, Cutting, Radiofrequency, Electrosurgical, Battery-Powered (NCR)1
- Tonometer, Analyzer, Ocular Blood Flow (NJJ)1
- Ocular Pattern Recorder (PLZ)1
- Applicator, Negative Pressure, External, Ocular (QQJ)1
- Knife, Intraocular Pressure Lowering (QUQ)1
Research
- Device studies on glaucoma across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.